Literature DB >> 14764767

Patients with classic congenital adrenal hyperplasia have decreased epinephrine reserve and defective glucose elevation in response to high-intensity exercise.

Martina Weise1, Sarah L Mehlinger, Bart Drinkard, Erin Rawson, Evangelia Charmandari, Mayumi Hiroi, Graeme Eisenhofer, Jack A Yanovski, George P Chrousos, Deborah P Merke.   

Abstract

Classic congenital hyperplasia (CAH) is characterized by impaired adrenocortical function with a decrease in cortisol and aldosterone secretion and an increase in androgen secretion. Adrenomedullary function is also compromised due to developmental defects in the formation of the adrenal medulla, leading to decreased production of epinephrine. To examine the response to a natural stressful stimulus in patients with classic CAH, we studied hormonal, metabolic, and cardiorespiratory parameters in response to a standardized high-intensity exercise protocol in nine adolescent patients with CAH and nine healthy controls matched for gender, age, and percent body fat. The same relative workload was applied, based on individual maximal aerobic capacity, and all patients received their usual glucocorticoid and mineralocorticoid replacement. When compared with their normal counterparts, patients with CAH had significantly lower epinephrine levels both at baseline and at peak exercise (P < 0.01), whereas norepinephrine levels did not differ. Blood glucose concentrations were similar at baseline, but the normal exercise-induced rise observed in the healthy controls was significantly blunted in the CAH patients (P < 0.01). Peak heart rate was also lower in CAH patients than healthy controls (P < 0.05). As expected, the normal exercise-induced increase in cortisol was not observed in patients with CAH. No significant differences were found in serum levels of insulin, glucagon, GH, lactate and free fatty acids, blood pressure, or ability to sustain exercise between the two groups. Patients with CAH replaced with glucocorticoids have decreased adrenomedullary reserve and impaired exercise-induced changes in glucose but normal short-term high-intensity exercise performance. Whether the combination of epinephrine and cortisol deficiency poses a risk for hypoglycemia and/or decreased endurance during long-term physical stress has to be determined.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14764767     DOI: 10.1210/jc.2003-030634

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  18 in total

Review 1.  Adrenal insufficiency.

Authors:  Stefanie Hahner; Richard J Ross; Wiebke Arlt; Irina Bancos; Stephanie Burger-Stritt; David J Torpy; Eystein S Husebye; Marcus Quinkler
Journal:  Nat Rev Dis Primers       Date:  2021-03-11       Impact factor: 52.329

2.  Adrenomedullary function in patients with nonclassic congenital adrenal hyperplasia.

Authors:  S Verma; L Green-Golan; C VanRyzin; B Drinkard; S P Mehta; M Weise; G Eisenhofer; D P Merke
Journal:  Horm Metab Res       Date:  2010-05-05       Impact factor: 2.936

3.  Patients with Bardet-Biedl syndrome have hyperleptinemia suggestive of leptin resistance.

Authors:  Penelope P Feuillan; David Ng; Joan C Han; Julie C Sapp; Katie Wetsch; Emma Spaulding; Yuqian C Zheng; Rafael C Caruso; Brian P Brooks; Jennifer J Johnston; Jack A Yanovski; Leslie G Biesecker
Journal:  J Clin Endocrinol Metab       Date:  2011-01-05       Impact factor: 5.958

Review 4.  Cortical-chromaffin cell interactions in the adrenal gland.

Authors:  Sven Schinner; Stefan R Bornstein
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

Review 5.  Clinical outcomes in the management of congenital adrenal hyperplasia.

Authors:  Henrik Falhammar; Marja Thorén
Journal:  Endocrine       Date:  2012-01-07       Impact factor: 3.633

6.  Glucocorticoid-deficient corticotropin-releasing hormone knockout mice maintain glucose requirements but not autonomic responses during repeated hypoglycemia.

Authors:  Lauren Jacobson; Tasneem Ansari; Jessica Potts; Owen P McGuinness
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-01-31       Impact factor: 4.310

7.  Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline.

Authors:  Phyllis W Speiser; Ricardo Azziz; Laurence S Baskin; Lucia Ghizzoni; Terry W Hensle; Deborah P Merke; Heino F L Meyer-Bahlburg; Walter L Miller; Victor M Montori; Sharon E Oberfield; Martin Ritzen; Perrin C White
Journal:  J Clin Endocrinol Metab       Date:  2010-09       Impact factor: 5.958

Review 8.  Cardiovascular disease risk in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  Mimi S Kim; Deborah P Merke
Journal:  Semin Reprod Med       Date:  2009-06-15       Impact factor: 1.303

Review 9.  Recent advances in diagnosis, treatment, and outcome of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  Felix G Riepe; Wolfgang G Sippell
Journal:  Rev Endocr Metab Disord       Date:  2007-12       Impact factor: 6.514

10.  Decreased adrenomedullary function in infants with classical congenital adrenal hyperplasia.

Authors:  Mimi S Kim; Anna Ryabets-Lienhard; Bhavna Bali; Christianne J Lane; Ashley H Park; Sandra Hall; Mitchell E Geffner
Journal:  J Clin Endocrinol Metab       Date:  2014-05-30       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.